Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best Boring Dividend Stocks to Buy. On November 24, Wells Fargo ...

Merck demonstrates excellence across the board through its resilient revenue mix, expanding profitability, and stellar ...

Merck & Co. is buying the developer of an experimental antiviral drug designed to prevent the flu, as the drugmaker aims to counter sales cliffs for two of its biggest drugs.

Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Out with the old, in with the new. The end of the year in biopharma is typically marked by pipeline clear-outs, and 2024 is proving it’s no different. In a day that already included discontinuations ...

Merck & Co (NYSE:MRK) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding ...

Merck has signed a 20-year Power Purchase Agreement with SK Innovation E&S for 16 MW renewable capacity at South Korea life ...

AZN and MRK boast major oncology strengths and expanding pipelines amid shifting market dynamics in this pharma matchup.

Shares U.S. Pharmaceuticals ETF offers growth and dividends from top holdings like LLY, JNJ, MRK with strong earnings and ...

New Jersey’s pharma sector faces new layoffs as Merck cuts 204 jobs and Bristol Myers Squibb plans 110 reductions amid ...

German science and technology company Merck KGaA has launched a supercomputer in Germany. Housed in an Equinix data center in ...

Financial giants have made a conspicuous bullish move on Merck & Co. Our analysis of options history for Merck & Co (NYSE:MRK) revealed 9 unusual trades. Delving into the details, we found 55% of ...